In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
A recent systematic review and meta-analysis published in Circulation (Gencer et al, 2021) looked at seven RCTs (81,210 patients) that examined the cardiovascular outcomes of marine omega-3 fatty acid supplementation.
The review found marine omega-3 supplementation was associated over time with an increased risk of atrial fibrillation, and that the risk was greater at daily doses of >1g.
Over the past two decades marine omega-3 fatty acid supplementation has been recommended, for healthy older adults and for cognitively impaired older adults, as being preventive/beneficial in relation to cognitive impairment.
The recommendations were usually for doses higher than 1g/d – so the results of this systematic review and meta-analysis are important for most patients using marine omega-3 fatty acid supplementation.
David Burke, BMed, DMedSc, MCPsychI, FRCPsych, FRANZCP
Clinical Lead and Senior Staff Specialist, Older People’s Mental Health Service
Associate Professor, Discipline of Psychiatry, University of Notre Dame, Sydney
Conjoint Senior Lecturer, School of Psychiatry, University of New South Wales, Sydney
Clinical Senior Lecturer, Department of Psychiatry, Trinity College, Dublin
Senior Associate, International Foundation for Integrated Care, Oxford
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
Immunisation weekly update – 8 February 2023 HPV vaccination now single dose on NIP Changes from 6 February 2023 to human papillomavirus vaccination (Gardasil®9) dose schedule under the National Immunisation Program: Routine schedule for people aged 12 to 13 years will change to a single dose (previously a 2 dose…
Sydney World Pride 2023 – General Practice Support CESPHN is a proud supporter of the Sydney WorldPride 2023 that is occurring from 17 February to 5 March 2023. To assist people to get the right care and avoid unnecessary presentations to emergency departments, we are encouraging general practices to review…
COVID-19 weekly update – 08 JANUARY 2023 ATAGI 2023 Booster Advice The Australian Technical Advisory Group on Immunisation (ATAGI) have updated their recommendations on the use of booster doses of COVID-19 vaccine in 2023. ATAGI recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their…
MEDIA RELEASE: Canterbury Head to Health service opens doors to offer free, immediate mental health support. Canterbury Head to Health opened its doors in late January, offering free and immediate support for anyone in Canterbury and the surrounding regions experiencing distress or mental health concerns.Trained professionals are providing short to…
CESPHN Vax at Home service The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and…
IAR-DST Training resumes today The implementation of the Initial Assessment and Referral Decision Support Tool (IAR-DST) training is gaining momentum both within CESPHN and nationally. National GP training numbers are closing in on 300 and over 50 of these have been trained by CESPHN. This year we are excited to…